🔎 Trials Near Me

Почетна › Плоскоклеточни карцином главе и врата › Kentaki › Louisville

Kliničke studije za Плоскоклеточни карцином главе и врата u gradu Louisville, KY

11 studija za Плоскоклеточни карцином главе и врата traži učesnike na lokacijama u gradu Louisville i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Тражи се учесникФаза 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Узраст од 18 до 79 · Оба пола · Ажурирано 12. 11. 2026. · NCT04671667

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Тражи се учесникФаза 1/2
  • Norton Cancer Institute, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Тражи се учесникФаза 2/3
  • Norton Cancer Institute (Site#0111), Louisville
  • The University of Louisville, James Graham Brown Cancer Center (Site#0115), Louisville
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06788990

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

Тражи се учесникФаза 2/3
  • Norton Cancer Institute, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06295731

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Тражи се учесникФаза 2
  • Norton Cancer Institute, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06769698

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Research Site 115, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

Тражи се учесникФаза 3
  • University of Louisville Health, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07768189

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Тражи се учесникФаза 1
  • Norton Cancer Institute, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05983432

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Тражи се учесникФаза 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT02734537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Тражи се учесникФаза 2
  • Baptist Health Floyd, New Albany · 4 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT06532279

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Тражи се учесникФаза 1
  • Norton Cancer Institute /ID# 248903, Louisville
Узраст 18 и старији · Оба пола · Ажурирано 23. 6. 2026. · NCT05005403

Studije za Плоскоклеточни карцином главе и врата u drugim gradovima

Ostale studije u gradu Louisville

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.